Oct 16, 2025 05:15
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
1.76 -0.12 (-6.82%) | 0.01 (0.61%) | 0.01 (0.61%) | -0.12 (-6.82%) | --- | --- | -0.12 (-6.82%) | -0.12 (-6.82%) |
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -0.09
- Diluted EPS:
- -0.09
- Basic P/E:
- -18.2222
- Diluted P/E:
- -18.2222
- RSI(14) 1m:
- 61.54
- VWAP:
- 1.65
- RVol:
- 0.0874
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price decrease 1m | 2.56 -0.04 (-1.54%) | Oct 16 06:56 |
1m | Price increase 1m | 2.6 +0.03 (+1.17%) | Oct 16 06:55 |
1m | Price increase 1m | 2.59 +0.06 (+2.37%) | Oct 16 06:53 |
1m | Price decrease 1m | 2.54 -0.03 (-1.17%) | Oct 16 06:52 |
10m | Price increase 10m | 2.58 +0.1 (+4.03%) | Oct 16 06:51 |
Related News
Aug 12, 2025 17:00
May 08, 2025 11:16
Feb 06, 2025 10:00
Mar 27, 2024 12:14
Mar 08, 2024 18:47
Mar 08, 2024 13:23
Feb 05, 2024 17:56
Nov 27, 2023 18:41
Nov 22, 2023 19:03